Latest News
ImmuCell Corporation
- ICCC Q2 2026 Earnings: ImmuCell Posts $0.20 EPS as Shares Climb 10% - Earnings Call Highlights
- ImmuCell Reports 46% Increase in Third-Quarter 2026 Sales
- ImmuCell (ICCC) Reports Strong Q3 2026 Sales Growth Amid Valuati
- ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
- ImmuCell Reports Preliminary Third Quarter 2026 Sales Up 46% to $8.0 Million
- ImmuCell reports 46% Q3 sales increase to $8.0 million By Investing.com
- ImmuCell reports 46% sales growth in Q3 2026, d...
- ImmuCell Corporation (ICCC) Holds Steady at $9.75 as Traders Watch Key Levels - Pullback Trade
Headlines from the last 30 days, linking to the original publishers. See all market news →